Protection against renal ischemia-reperfusion injury in vivo by the mitochondria targeted antioxidant MitoQ

Redox Biology

Volumn 5, Issue , 2015, Pages 163-168

  Dare, Anna J ^a   Bolton, Eleanor A ^b   Pettigrew, Gavin J ^b   Bradley, J Andrew ^b   Saeb Parsy, Kourosh ^b   Murphy, Michael P ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Ischemia reperfusion injury; Kidney; Mitochondria; Mitochondria targeted antioxidants; MitoQ; Oxidative damage

Indexed keywords

ANTIOXIDANT; MITO Q; UNCLASSIFIED DRUG; 10-(6'-UBIQUINONYL)DECYLTRIPHENYLPHOSPHONIUM BROMIDE; CREATININE; ORGANOPHOSPHORUS COMPOUND; UBIQUINONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG EFFICACY; DRUG MECHANISM; IN VIVO STUDY; KIDNEY BLOOD VESSEL; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY ISCHEMIA; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RENAL PROTECTION; REPERFUSION INJURY; ANALOGS AND DERIVATIVES; ANIMAL; C57BL MOUSE; DRUG EFFECTS; KIDNEY; METABOLISM; MITOCHONDRION; PATHOLOGY;

MUS;

ANIMALS; ANTIOXIDANTS; CREATININE; KIDNEY; MALE; MICE; MICE, INBRED C57BL; MITOCHONDRIA; ORGANOPHOSPHORUS COMPOUNDS; OXIDATIVE STRESS; REPERFUSION INJURY; UBIQUINONE;

EID: 84930939650     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2015.04.008     Document Type: Article

References (41)

1. Simmons M.N., Schreiber M.J., Gill I.S. Surgical renal ischemia: a contemporary overview. Journal of Urology 2008, 180(1):19-30. http://www.ncbi.nlm.nih.gov/pubmed/18485395, 10.1016/j.juro.2008.03.022.
2. Schrier R.W., Belz M.M., Johnson A.M., Kaehny W.D., Hughes R.L., Rubinstein D., Gabow P.A. Repeat imaging for intracranial aneurysms in patients with autosomal dominant polycystic kidney disease with initially negative studies: a prospective ten-year follow-up. Journal of American Society of Nephrology 2004, 15(4):1023-1028. http://www.ncbi.nlm.nih.gov/pubmed/15034105, 10.1097/01.ASN.0000118527.74850.66.
3. Himmelfarb J.M., Joannidis M., Molitoris B., Schietz M., Okusa M.D., Warnock D., Laghi F., Goldstein S.L., Prielipp R., Parikh C.R., Pannu N., Lobo S.M., Shah S., D'Intini V., Kellum J.A. Evaluation and initial management of acute kidney injury. Clinical Journal of American Society of Nephrology 2008, 3(4):962-967. http://www.ncbi.nlm.nih.gov/pubmed/18354074, 10.2215/CJN.04971107.
4. Chertow G.M. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. Journal of the American Society of Nephrology 2005, 16(11):3365-3370. 10.1681/ASN.2004090740.
5. Gueler F., Gwinner W., Schwarz A., Haller H. Long-term effects of acute ischemia and reperfusion injury. Kidney International 2004, 66(2):523-527. http://www.ncbi.nlm.nih.gov/pubmed/15253702, 10.1111/j.1523-1755.2004.761_11.x.
6. Venkataraman R. Can we prevent acute kidney injury?. Critical Care Medicine 2008, 36(4 Suppl.):S166-S171. http://www.ncbi.nlm.nih.gov/pubmed/18382189, 10.1097/CCM.0b013e318168c74a.
7. Qin C., Yap S.W., Woodman O.L. Antioxidants in the prevention of myocardial ischemia/reperfusion injury. Expert Review in Clinical Pharmacology 2009, 2(6):673-695. http://www.ncbi.nlm.nih.gov/pubmed/22112260, 10.1586/ecp.09.41.
8. Devarajan P. Update on mechanisms of ischemic acute kidney injury. Journal of American Society of Nephrology 2006, 17(6):1503-1520. http://www.ncbi.nlm.nih.gov/pubmed/16707563, 10.1681/ASN.2006010017.
9. Ambrosio G., Flaherty J.T., Duilio C., Tritto I., Santoro G., Elia P.P., Condorelli M., Chiariello M. Oxygen radicals generated at reflow induce peroxidation of membrane lipids in reperfused hearts. Journal of Clinical Investigation 1991, 87(6):2056-2066. http://www.ncbi.nlm.nih.gov/pubmed/1645750, 10.1172/JCI115236.
10. G.Ambrosio, J.L.Zweier, C.Duilo, P.Kuppusamy, G.E.Santorno, P.P.Tritto, I. Crillo, P.Condorelli, M.Chiariello, M.Flaherty, J.T.[!(%xInRef|ce:surname)!] J.T. Evidence that mitochondrial respiration is a source of potentially toxic oxygen free radical in intact rabbit hearts subjected to ischemia and reflow. Journal of Biological Chemistry 1993, 268(25):18432-18541. http://www.ncbi.nlm.nih.gov/pubmed/8395507.
11. Turrens J.F., Beconi M., Barilla J., Chavez U.B., McCord J.M. Mitochondrial generation of oxygen radicals during reoxygenation of ischemic tissues. Free Radical Research Communication 1991, 12-13(2):681-689. http://www.ncbi.nlm.nih.gov/pubmed/2060840, 10.3109/10715769109145847.
12. Bulteau A.L., Lundberg K.C., Humphries K.M., Sadek H.A., Szweda P.A., Friguet B., Szweda L.I. Oxidative modification and inactivation of the proteasome during coronary occlusion/reperfusion. Journal of Biological Chemistry 2001, 276(32):30057-30063. http://www.ncbi.nlm.nih.gov/pubmed/11375979, 10.1074/jbc.M100142200.
13. Di Lisa F.P., Bernardi P. Mitochondria and ischemia-reperfusion injury of the heart fixing a hole. Cardiovascular Research 2006, 70(2):191-199. http://www.ncbi.nlm.nih.gov/pubmed/16497286, 10.1016/j.cardiores.2006.01.016.
14. Lesnefsky E.J., Moghaddas S., Tandler B., Kerner J., Hoppel C.L. Mitochondrial dysfunction in cardiac disease: ischemia-reperfusion, aging and heart failure. Journal of Molecular and Cellular Cardiology 2001, 33(6):1065-1089. http://www.ncbi.nlm.nih.gov/pubmed/11444914, 10.1006/jmcc.2001.1378.
15. Mukhopadhyay P., Horváth B., Zsengeller Z., Bátkai S., Cao Z., Kechrid M., Holovac E., Erdelyi K., Tanchian G., Liaudet L., Stillman I.E., Joseph J., Kalyanaraman B., Pacher P. Mitochondrial reactive oxygen species generation triggers inflammatory response and tissue injury associated with hepatic ischemia-reperfusion: therapeutic potential of mitochondrially targeted antioxidants. Free Radical Biology and Medicine 2012, 53(5):1123-1138. http://www.ncbi.nlm.nih.gov/pubmed/22683818, 10.1016/j.freeradbiomed.2012.05.036.
16. Zhou R., Yazdi A.S., Menu P., Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature 2011, 469(7329):221-225. http://www.ncbi.nlm.nih.gov/pubmed/21124315, 10.1038/nature09663.
17. Oka T., Hikoso S., Yamaguchi O., Taneike M., Takeda T., Tamai T., Oyabu J., Murakawa T., Nakayama H., Nishida K., Akira S., Yamamoto A., Komuro I., Otsu K. Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure. Nature 2012, 485(7397):251-255. http://www.ncbi.nlm.nih.gov/pubmed/22535248, 10.1038/nature10992.
18. Munshi R., Hsu C., Himmelfarb J. Advances in understanding ischemic acute kidney injury. BMC Medicine 2011, 9:11. http://www.ncbi.nlm.nih.gov/pubmed/21288330, 10.1186/1741-7015-9-11.
19. Smith R.A.J., Hartley R.C., Cochemé H.M., Murphy M.P. Mitochondrial pharmacology. Trends in Pharmacological Science 2012, 33(6):341-352. http://www.ncbi.nlm.nih.gov/pubmed/22521106, 10.1016/j.tips.2012.03.010.
20. Smith R.A., Hartley R.C., Murphy M.P. Mitochondria-targeted small molecule therapeutics and probes. Antioxidants and Redox Signalling 2011, 15(12):3021-3038. http://www.ncbi.nlm.nih.gov/pubmed/21395490, 10.1089/ars.2011.3969.
21. Cochemé H.M., Murphy M.P. Can antioxidants be effective therapeutics?. Current Opinion in Investigational Drugs 2010, 11:426-431.
22. Smith R.A.J., Murphy M.P. Animal and human studies with the mitochondria-targeted antioxidant MitoQ. Annals of New York Academy of Science 2010, 1201:96-103. http://www.ncbi.nlm.nih.gov/pubmed/20649545, 10.1111/j.1749-6632.2010.05627.x.
23. Kelso G.F., Porteous C.M., Coulter C.V., Hughes G., Porteous W.K., Ledgerwood E.C., Smith R.A.J., Murphy M.P. Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties. Journal of Biological Chemistry 2001, 276(7):4588-4596. http://www.ncbi.nlm.nih.gov/pubmed/11092892, 10.1074/jbc.M009093200.
24. Prime T.A., Forkink M., Logan A., Finichiu P.G., McLachlan J., Li Pun P.B., Koopman W.J., Larsen L., Latter M.J., Smith R.A., Murphy M.P. A ratiometric fluorescent probe for assessing mitochondrial phospholipid peroxidation within living cells. Free Radical Biology and Medicine 2012, 53(3):544-553. http://www.ncbi.nlm.nih.gov/pubmed/22659314, 10.1016/j.freeradbiomed.2012.05.033.
25. James A.M., Cochemé H.M., Smith R.A.J., Murphy M.P. Interactions of mitochondria-targeted and untargeted ubiquinones with the mitochondrial respiratory chain and reactive oxygen species. Implications for the use of exogenous ubiquinones as therapies and experimental tools. Journal of Biological Chemistry 2005, 280(22):21295-21312. http://www.ncbi.nlm.nih.gov/pubmed/15788391, 10.1074/jbc.M501527200.
26. James A.M., Sharpley M.S., Manas A.R., Frerman F.E., Hirst J., Smith R.A., Murphy M.P. Interaction of the mitochondria-targeted antioxidant MitoQ with phospholipid bilayers and ubiquinone oxidoreductases. Journal of Biological Chemistry 2007, 282(20):14708-14718. http://www.ncbi.nlm.nih.gov/pubmed/17369262, 10.1074/jbc.M611463200.
27. Snow B.J., Rolfe F.L., Lockhart M.M., Frampton C.M., O'Sullivan J.D., Fung V., Smith R.A.J., Murphy M.P., Taylor K.M. A double-blind, placebo controlled study to assess the mitochondria targeted antioxidant MitoQ as a disease modifying therapy in Parkinson's disease. Movement Disorders 2010, 25(11):1670-1674. Protect Study Group. http://www.ncbi.nlm.nih.gov/pubmed/20568096, 10.1002/mds.23148.
28. Gane E.J., Weilert F., Orr D.W., Keogh G.F., Gibson M., Lockhart M.M., Frampton C.M., Taylor K.M., Smith R.A.J., Murphy M.P. The mitochondria-targeted antioxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients. Liver International 2010, 30(7):1019-1026. http://www.ncbi.nlm.nih.gov/pubmed/20492507, 10.1111/j.1478-3231.2010.02250.x.
29. Smith R.A.J., Porteous C.M., Gane A.M., Murphy M.P. Delivery of bioactive molecules to mitochondria in vivo. Proceedings of the National Academy of Science USA 2003, 100(9):5407-5412. http://www.ncbi.nlm.nih.gov/pubmed/12697897, 10.1073/pnas.0931245100.
30. Porteous C.M., Logan A., Evans C., Ledgerwood E.C., Menon D.K., Aigbirhio F., Smith R.A.J., Murphy M.P. Rapid uptake of lipophilic triphenylphosphonium cations by mitochondria in vivo following intravenous injection: implications for mitochondria-specific therapies and probes. Biochimica et Biophysica Acta 2010, 1800(9):1009-1017. http://www.ncbi.nlm.nih.gov/pubmed/20621583, 10.1016/j.bbagen.2010.06.001.
31. Adlam V.J., Harrison J.C., Porteous C.M., James A.M., Smith R.A.J., Murphy M.P., Sammut I.A. Targeting an antioxidant to mitochondria decreases cardiac ischemia reperfusion injury. FASEB Journal 2005, 19(9):1088-1095. http://www.ncbi.nlm.nih.gov/pubmed/15985532, 10.1096/fj.05-3718com.
32. Neuzil J., Widén C., Gellert N., Swettenham E., Zobalova R., Dong L.F., Wang X.F., Lidebjer C., Dalen H., Headrick J.P., Witting P.K. Mitochondria transmit apoptosis signalling in cardiomyocyte-like cells and isolated hearts exposed to experimental ischemia-reperfusion injury. Redox Reports 2007, 12(3):148-162. http://www.ncbi.nlm.nih.gov/pubmed/17623522, 10.1179/135100007X200227.
33. Mitchell T., Rotaru D., Saba H., Smith R.A., Murphy M.P., MacMillan-Crow L.A. The mitochondria-targeted antioxidant mitoquinone protects against cold storage injury of renal tubular cells and rat kidneys. Journal of Pharmacology and Experimental Therapeutics 2011, 336(3):682-692. http://www.ncbi.nlm.nih.gov/pubmed/21159749, 10.1124/jpet.110.176743.
34. Chacko B.K., Reily C., Srivastava A., Johnson M.S., Ye Y., Ulasova E., Agarwal A., Zinn K.R., Murphy M.P., Kalyanaraman B., Darley-Usmar V. Prevention of diabetic nephropathy in Ins2(+/)(-)(AkitaJ) mice by the mitochondria-targeted therapy MitoQ. Biochemistry Journal 2010, 432(1):9-19. http://www.ncbi.nlm.nih.gov/pubmed/20825366, 10.1042/BJ20100308.
35. Santos J.H., Meyer J.N., Mandavilli B.S., Van Houten B. Quantitative PCR-based measurement of nuclear and mitochondrial DNA damage and repair in mammalian cells. Methods in Molecular Biology 2006, 314:183-199. http://www.ncbi.nlm.nih.gov/pubmed/16673882, 10.1385/1-59259-973-7:183.
36. Rodriguez-Cuenca S., Cochemé H.M., Logan A., Abakumova I., Prime T.A., Rose C., Vidal-Puig A., Smith A.C., Rubinsztein D.C., Fearnley I.M., Jones B.A., Pope S., Heales S.J., Lam B.Y., Neogi S.G., McFarlane I., James A.M., Smith R.A., Murphy M.P. Consequences of long-term oral administration of the mitochondria-targeted antioxidant MitoQ to wild-type mice. Free Radical Biology and Medicine 2010, 48(1):161-172. http://www.ncbi.nlm.nih.gov/pubmed/19854266, 10.1016/j.freeradbiomed.2009.10.039.
37. Hunter S.E., Jung D., Di Giulio R.T., Meyer J.N. The QPCR assay for analysis of mitochondrial DNA damage, repair, and relative copy number. Methods 2010, 51(4):444-451. http://www.ncbi.nlm.nih.gov/pubmed/20123023, 10.1016/j.ymeth.2010.01.033.
38. Winterbourn C.C., Buss I.H. Protein carbonyl measurement by enzyme-linked immunosorbent assay. Methods in Enzymology 1999, 300:106-111. http://www.ncbi.nlm.nih.gov/pubmed/9919514, 10.1016/S0076-6879(99)00118-4.
39. Vanderlelie J., Venardos K., Clifton V.L., Gude N.M., Clarke F.M., Perkins A.V. Increased biological oxidation and reduced anti-oxidant enzyme activity in pre-eclamptic placentae. Placenta 2005, 26(1):53-58. http://www.ncbi.nlm.nih.gov/pubmed/15664411, 10.1016/j.placenta.2004.04.002.
40. Chiao H., Kohda Y., McLeroy P., Craig L., Housini I., Star R.A. Alpha-melanocyte-stimulating hormone protects against renal injury after ischemia in mice and rats. Journal of Clinical Investigation 1997, 99(6):1165-1172. http://www.ncbi.nlm.nih.gov/pubmed/9077523, 10.1172/JCI119272.
41. Williams P., Lopez H., Britt D., Chan C., Ezrin A., Hottendorf R. Characterization of renal ischemia-reperfusion injury in rats. Journal of Pharmacological and Toxicological Methods 1997, 37(1):1-7. http://www.ncbi.nlm.nih.gov/pubmed/9086282, 10.1016/S1056-8719(96)00141-4.